The alkaloid cryptolepine (1) and eight synthetic analogues (2-8) were assessed for in vitro activities against Trypanosoma brucei. Four of the analogues were found to be highly potent with IC50 values of less than 3 nM and three of these were assessed against T. brucei brucei infection in rats. The most effective compound was 2, 7-dibromocryptolepine (7); a single oral dose of 20 mg/kg suppressed parasitaemia and increased the mean survival time to 13.6 days compared with 8.4 days for untreated controls. In addition, four huperzine derivatives (9-12) were shown to have in vitro antitrypanosomal activities with IC50 values ranging from 303-377 nM.
WelburnSC, ColemanPG, MaudlinI, FevreEM, OdiitM, EislerMC. (2006) Crisis, what crisis? Control of Rhodesian sleeping sickness. Trends in Parasitology, 22, 123–128.
4.
WrightCW, Addae-KyeremeJ, BreenAG, BrownJE, CoxMF, CroftSL, GokcekY, KendrickH, PhillipsRM, PolletP. (2001) Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. Journal of Medicinal Chemistry, 44, 3187–3194.
5.
OnyeiborO, CroftSL, DodsonHI, Feiz-HaddadM, KendrickH, MillingtonNJ, ParapiniS, PhillipsRM, SevilleS, ShnyderSD, TaramelliD, WrightCW. (2005) Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action. Journal of Medicinal Chemistry, 48, 2701–2709.
6.
MaX, TanC, ZhuD, GangDR, XiaoP. (2007) Huperzine A from Huperzia species - An ethnopharmacological review. Journal of Ethnopharmacology, 113, 15–34.
7.
LisgartenJN, CollM, PortugalJ, WrightCW, AymamiJ. (2002) The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites. Nature Structural Biology, 9, 57–60.
8.
BonjeanK, de Pauw-GilletMC, DefresneMP, ColsonP, HoussierC, DassonevilleL, BaillyC, GreimersR, WrightC, Quetin-LeclercqJ, TitsM, AngenotL. (1998) The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry, 37, 5136–5146.
9.
RojasM, WrightCW, PinaB, PortugalJ (2008) Genome-wide expression profiling of cryptolepine-induced toxicity in Saccharomyces cerevisiae. Antimicrobial Agents and Chemotherapy, 52, 3844–3850.
10.
CampsP, CussackB, MallenderWD, El AchabR, MorralJ, Munoz-TorreroD, RosenberryTL. (2000) Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease. Molecular Pharmacology, 57, 409–417.
11.
CampsP, ContrerasJ, Font-BardiaM, MorralJ, Munoz-TorreroD, SolansX. (1998) Enantioselective synthesis of tacrine-huperzine A hybrids. Preparative chiral MPLC separation of their racemic mixtures and absolute configuration assigments by X-ray diffraction analysis. Tetrahedron: Asymmetry, 9, 835–849.
12.
CampsP, El AchabR, GorbigDM, MorralJ, Munoz-TorreroD, BadiaA, BanosJE, VivasNM, BarrilX, OrozcoM, LuqueFJ. (1999) Synthesis, in vitro pharmacology and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. Journal of Medicinal Chemistry, 42, 3227–3242.
13.
MackeyZB, BacaAM, MallariJP, ApselB, ShelatA, HansellJ, ChiangPK, WolffB, GuyKR, WilliamsJ, McKerrowJH. (2006) Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chemical and Biological Drug Design67, 355–363.
14.
ZweygarthE, KaminskyR. (1991) Evaluation of DL-α-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei. Acta Tropica, 48, 223–232.
15.
DanielAD, DadahAT, KaleejaiyeJO, DalhatuAD. (1993) Prevalence of bovine trypanosomiasis in Gongola state of Northern Nigeria. Revue d’ Elevage Medecine Veterinaire des Pays Tropicaux (Paris), 46, 571–574.
